[1]Bergstrom JP, Helander A. Clinicalcharacteristics of carbohydrate deficient transferrin(%disialotransferrin)measured by HPLC:sensitivity,sp ecificity,gender effects,and relationship with other alcohol biomarkers[J]. Alcohol Alcohol,2008,43(4):436-441.
[2]Gjerdrum C, Tiron C, Hiby T,et al.Axl is an essential epithelial-to-me senchymal transitioninduced regulator of breast cancer metastasis and Patient survival[J].Proc Natl Acad Sci USA,2010,107(3):1121-1129.
[3]Huang G,Hou JG,Xu ChL,et al. The expression of Axl and its ligand protein of cell and tissue in prostate cancer and its clinical significance[J].Chinese Journal of Cancer Biotherapy,2009,16(3):282-286. (in Chinese)
黄钢,侯建国,许传亮,等.前列腺癌细胞和组织中Axl及其配体蛋白的表达与临床意义[J].中国肿瘤生物治疗杂志,2009,16(3): 282-286.
[4]He L, Zhang J, Jiang L, et al. Differential expression of Axl in hepatocellular carcinoma and correlation with tumor lymphatic metastasis[J].Mol Carcinog,2010,49(10):882-891.[5]Sherman SI. Thyroid carcinoma[J].Lancet,2003,361(9356):501-511.
[6]Koorstra JB, Karikari CA, Feldmann G, et al. The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target [J]. Cancer Biol Ther, 2009, 8(7): 618-626.
[7]Avilla E, Guarino V, Visciano C,et al. Activation of TYRO3/AXL tyrosine kinase receptors in thyroid cancer[J].Cancer Res,2011,71(5):1792-1804.
[8]Ito M, Nakashima M, Nakayama T,et al. Expression of receptor-type tyrosine kinase, Axl, and its ligand,Gas6,in pediatric thyroid carcinomas around Chernoby[J].Thyroid.2002,12(11):971-975.
[9]Ito T, Ito M, Naito S,et al. Expression of the Axl receptor tyrosine kinase in human thyroid carcinoma[J].Thyroid,1999,9(6):563-567.
[10]Krishnamoorthy GP,Guida T,Alfano L, et al. Molecular mechanism of 17-allylamino-17-demethoxygeldanamycin(17-AAG)induced AXLreceptor tyrosine kinase degradation [J]. J Biol Chem,2013,288(24):17481-17494.
[11]Chaker S, Kashat L, Voisin S, et al. Secretome proteins as ca ndidate biomarkers for aggressive thyroid carcinomas[J]. Proteomics.2013,13(5): 771-787.
[12]Li Y, Ye X, Tan C, et al. Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angi ogenesis[J]. Oncogene, 2009, 28(39):3442-3455.
[13]Sawabu T, Seno H, Kawashima T, et al. Growth arrest-specific gene6 and signaling enhances gastric cancer cell survival via Akt pathway[J].Mol Carcino,2007,46(2):155-164.
[14]Zhang YX,Knyazev PG,Cheburkin YV,et al.AXL is a potential target for therapeutic intervention in breast cancer progression[J].Canceres, 2008,68(6):1905-1915.
[15]Shieh YS,Lai CY,Kao YR,et al.Expression of Axl in lung adenocar cinoma and correlation with tumor progression[J].Neoplasia,2005,7 (12):1058-1064.
[16]Craven RJ, Xu LH,Weiner TM, et al. Receptor tyrosine kinases expressed in metastatic colon cancer[J].Int J Cancer, 1995, 60(6):791-797.
[17]Hasanbasic L,Cuerquis J,Varnum B,et al.Intracellular signaling path ways involved in Gas6-Axl-mediated suivival of endothelial cells[J]. Am J Physiol Heart Circ Physiol,2004,287(3):H1207-H1213.
[18]Zeng Q,Chen GG,Vlantis AC,et al.Oestrogen mediates the growth of hum an thyroid carcinoma cells via an oestrogen receptor-ERK pathway [J].Cell Prolif,2007,40(6):921-935. |